Value based pricing for NHS medicines: magic bullet, counterfeit treatment or the mixture as before?

Publisher： Cambridge University Press

E-ISSN： 1744-134x|4|4|515-526

ISSN： 1744-1331

Source： Health Economics, Policy and Law, Vol.4, Iss.4, 2009-10, pp. : 515-526

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Usage-Based versus Measure-Based Unit Pricing: Is there a Better Index of Value?

By Kwortnik Robert   Creyer Elizabeth   Ross William  

Journal of Consumer Policy, Vol. 29, Iss. 1, 2006-03 ,pp. : 37-66

Springer Publishing Company

Access to resources Recommend Favorite

Marginal value-based pricing of additional spectrum assigned to cellular telephony operators

By Sweet R.   Viehoff I.   Linardatos D.   Kalouptsidis N.  

Information Economics and Policy, Vol. 14, Iss. 3, 2002-09 ,pp. : 371-384

Elsevier

Access to resources Recommend Favorite

Valuing Trial Designs from a Pharmaceutical Perspective Using Value‐Based Pricing

By  

HEALTH ECONOMICS, Vol. 1057-9230, Iss. 11, 2015-11 ,pp. : 1468-1482

John Wiley & Sons Inc

Access to resources Recommend Favorite

Value‐Based Differential Pricing: Efficient Prices for Drugs in a Global Context

By  

HEALTH ECONOMICS, Vol. 24, Iss. 3, 2015-03 ,pp. : 294-301

John Wiley & Sons Inc

Access to resources Recommend Favorite

Valuing Trial Designs from a Pharmaceutical Perspective Using Value‐Based Pricing

By  

HEALTH ECONOMICS, Vol. 24, Iss. 11, 2015-11 ,pp. : 1468-1482

John Wiley & Sons Inc

Access to resources Recommend Favorite